Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer.
Join our team at Iovance Biotherapeutics, a leading innovator in the cell therapy industry, where we’re passionate about saving lives and fostering a collaborative, inclusive environment.
Overview
The Director of Scientific Marketing, Melanoma is a member of Iovance’s US Marketing Cell Therapy team, with accountability for developing the strategic direction for scientific strategy and medical education activities supporting AMTAGVI, the only FDA approved T Cell Therapy for Metastatic Melanoma. Primary focus will be on the Advanced Melanoma market but will evolve over time to support additional indications as pipeline programs mature.
The ideal candidate is someone with experience in metastatic melanoma or with prior Cell Therapy Scientific Marketing experience. The candidate needs to have an entrepreneurial spirit looking for an opportunity to be part of the first-in-class launch of an innovative cell therapy for metastatic melanoma. The Director of Scientific Marketing will report to the Head of Marketing.
Essential Functions and Responsibilities